We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Proactive Technology Helps Keep Chest Tubes Clear

By HospiMedica International staff writers
Posted on 23 Aug 2016
Print article
Image: The PleuraFlow system with Active Clearance Technology (ACT) (Photo courtesy of ClearFlow).
Image: The PleuraFlow system with Active Clearance Technology (ACT) (Photo courtesy of ClearFlow).
A new system proactively clears chest tubes and prevents the retention of blood and fluids in the chest cavity of cardiothoracic surgery patients.

The PleuraFlow Active Clearance Technology (ACT) system is used to maintain chest tube patency and reduce potential retained blood syndrome (RBS). The system is indicated for use during cardiothoracic surgical procedures and chest trauma. Comprised of a silicone chest tube and a clearance apparatus, the system uses ACT proactively to remove clots formed inside a chest tube to prevent or minimize chest tube occlusion, and to enable evacuation of blood and fluid from the operative site after closure of the surgical wound.

The clearance apparatus consists of a guide tube and a polytetrafluoroethylene (PTFE) -coated clearance wire with a loop set on its distal end, bent at a 105-degree angle. The clearance apparatus is advanced into the PleuraFlow Chest tube using a magnetic shuttle. When indicated, the clearance wire and loop is advanced and retracted within the chest tube to proactively prevent or break up and clear any tube obstructions or clogging, keeping the chest tube patent and allowing fluid flow to the drainage canister.

The PleuraFlow Chest Tube is available in four standard sizes. These include a 20 Fr System with four side holes, intended for infant, preadolescent, and adolescent patients undergoing congenital cardiac surgery; a 20 Fr with 6 side holes for a higher flow rate; and 24 Fr and 38 Fr tubes for larger pediatric patients. Each chest tube has a cut length of 48.3 cm, with graduated measurements in centimeters from the distal eyelet, and a barium stripe to facilitate radiographic visualization. The PleuraFlow System is a product of ClearFlow (Anaheim, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

“We commonly hear from pediatric heart surgeons, pediatric intensive care specialists and ICU nurses that they encounter problems with chest tube clogging after heart surgery in children, and sometimes this results in preventable major complications or even fatal consequences,” said Paul Molloy, CEO of ClearFlow. “The older makeshift bedside techniques of stripping or milking conventional chest tubes have been shown ineffective to prevent these problems, and can even be harmful, and thus are banned in many hospitals.”

RBS is a composite of drainage-related complications that are detrimental to outcomes following cardiothoracic surgery and that may require early or late intervention to remediate. These clinical complications have significant economic consequences, including higher costs of care for patients, hospitals, and society at large.

Related Links:
ClearFlow


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Endoscope Tracking Software
T-DOC Endo

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.